Endothelin in renal pathophysiology: From experimental to therapeutic application

Kidney International

Volumn 50, Issue 6, 1996, Pages 1827-1833

  Rabelink, Ton J ^a,b   Kaasjager, Karin A H ^a   Stroes, Erik S G ^a   Koomans, Hein A ^a  

^a University Hospital Utrecht ^*

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ENDOTHELIN; ENDOTHELIN RECEPTOR;

HUMAN; KIDNEY DISEASE; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW;

EID: 0029960587     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1038/ki.1996.502     Document Type: Article

References (115)

1. YANAGISAWA M, KURIHARA H, KIMURA S, TOMBE Y, KOBAYASHI M, YAZAKI Y, GOTO K, MASAKI T: A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature 332:411-415, 1988
2. LÜSCHER TF, BOCK HA, YANG Z, DIEDERICH D: Endothelium-derived relaxing and contracting factors: Perspectives in nephrology. Kidney Int 39:575-590, 1991
3. KON V, BADR KF: Biological actions and pathophysiological significance of endothelin in the kidney. Kidney Int 40:1-12, 1991
4. PERICO N, REMUZZI G: Role of endothelin in glomerular injury. Kidney Int 39(Suppl 39):S76-S80, 1993
5. NORD EP: Renal actions of endothelin. Kidney Int 44:451-463, 1993
6. MARSEN TA, SCHRAMEK H, DUNN MJ: Renal activity of endothelin: Linking cellular signaling pathways to disease. Kidney Int 45:336-344, 1994
7. XU D, EMOTO N, GIAID A, SLAUGHTER C, KAW S, DEWIT D, YANAGISAWA M: ECE-1: A membrane-bound metalloprotease that catalyzes the proteolytic activation of big endothelin-1. Cell 78:473-485, 1994
8. KOHAN DE: Endothelin synthesis by renal tubule cells. Am J Physiol 261:F221-F226, 1991
9. KOHAN DE: Production of endothelin-1 by rat mesangial cells: Regulation by tumor necrosis factor. J Lab Clin Med 119:477-484, 1992
10. KOHAN DE: Endothelin production by human inner medullary collecting ducts. J Am Soc Nephrol 3:1719-1721, 1993
11. KASINATH BS, FRIED TA, DAVALATH S, MARSDEN PA: Glomerular epithelial cells synthesize endothelin peptides. Am J Pathol 141:279-283, 1992
12. KARET FE, DAVENPORT AP: Localization of endothelin peptides in human kidney. Kidney Int 49:382-387, 1996
13. KURIHARA H, YOSHIZUMI M, SUGIYAMA T, TAKAKU F, YANAGISAWA M, MASAKI T, HAMAOKI M, KATO H, YAZAKI Y: Transforming growth factor-β stimulates the expression of endothelin mRNA by vascular endothelial cells. Biochem Biophys Res Commun 159:1435-1440, 1989
14. IMAI T, HIRATA Y, EMORI T, YANAGISAWA M, MASAKI T, MARUMO F: Induction of endothelin-1 gene by angiotensin and vasopressin in endothelial cells. Hypertension 19:753-757, 1992
15. B in human kidney. Kidney Int 44:36-42, 1993
16. NAMBI P, PULLEN M, WU HL, AIYAR N, OHLSTEIN EH, EDWARDS RM: Identification of endothelin receptor subtypes in human renal cortex and medulla using subtype-selective ligands. Endocrinology 131:1081-1086, 1992
17. RESINK TJ, SCOTT-BURDEN T, BOULANGER C, WEBER E, BÜHLER FR: Internalization of endothelin by cultured human vascular smooth muscle cells: Characterization and physiological significance. Mol Pharmacol 38:244-252, 1990
18. SHIBA R, YANAGISAWA M, MIYAUCHI T, ISHII Y, KIMURA S, UCHIYAMA Y, MASAKI T, GOTO K: Elimination of intravenously injected endothelin-1 from the circulation of the rat. J Cardiovasc Pharmacol 13(Suppl 5):S98-S101, 1989
19. VIERHAPPER H, WAGNER O, WALDHAUSL W: Effect of endothelin-1 in man. Circulation 81:1415-1418, 1990
20. MARSAULT R, FEOLDE E, FRELIN C: Receptor externalization determines sustained contractile responses to endothelin-1 in the rat aorta. Am J Physiol 264:C687-C693, 1993
21. POLLOCK D, DIVISH B, POLAKOWSKI J, OPGENORTH T: Effect of the endothelin ETA receptor antagonist, BQ-123, on pressor responses to endothelin family peptides. Endothelium 1:55-59, 1993
22. SIMONSON MS, DUNN MJ: Cellular signalling by peptides of the endothelin gene family. FASEB J 4:2989-3000, 1990
23. OPGENORTH TJ: Endothelin receptor antagonism. Adv Pharmacol 33:1-66, 1995
24. BAKRIS GL, RE RN: Endothelin modulates angiotensin II-induced mitogenesis of human mesangial cells. Am J Physiol 264:F937-F942, 1993
25. FLOEGE J, ENG E, YOUNG BA, JOHNSON RJ: Factors involved in the regulation of mesangial cell proliferation, in vitro and in vivo. Kidney Int 43(Suppl 39):S47-S54, 1993
26. + exchange, c-fos expression, and mitogenesis in rat mesangial cells. J Clin Invest 83:708-712, 1989
27. KURIHARA Y, KURIHARA H, SUZUKI H, KODAMA T, MAEMURA K, NAGAI R, ODA H, KUWAKI T, CAO WH, KAMADA N, JISHAGE K, OUCHI Y, AZUMA S, TOYODA Y, ISHIKAWA T, KUMADA M, YAZAKI Y: Elevated blood pressure and craniofacial abnormalities in mice deficient in endothelin-1. Nature 368:703-710, 1994
28. BADR KF, MURRAY JJ, BREYER MD, TAKAHASHI K, INAGAMI T, HARRIS RC: Mesangial cell, glomerular and renal vascular responses to endothelin in the rat kidney: Elucidation of signal transduction pathways. J Clin Invest 83:336-342, 1989
29. RABELINK TJ, KAASJAGER KAH, BOER P, STROES EG, BRAAM B, KOOMANS HA: Effects of endothelin-1 on renal function in humans: Implications for physiology and pathophysiology. Kidney Int 46:376-381, 1994
30. BIJLSMA JA, RABELINK TJ, KAASJAGER KAH, KOOMANS HA: L-Arginine does not prevent the renal effects of endothelin in humans. J Am Soc Nephrol 5:1508-1516, 1995
31. +-ATPase in intact renal tubular epithelial cells. Am J Physiol 257:C1101-1107, 1989
32. TOMITA K, NONOGUCHI H, TERADA Y, MARUMO F: Effects of ET-1 on water and chloride transport in cortical collecting ducts of the rat. Am J Physiol 264:F690-F696, 1993
33. A receptors in the perfused rabbit kidney. Eur J Pharmacol 237:275-281, 1993
34. A receptor-mediated responses to endothelin-1 and big endothelin-1 in the rat kidney. Br J Pharmacol 11:729-732, 1994
35. DAVIS LS, HALEEN SJ, DOHERTY AM, CODY WL, KEISER JA: Effects of selective endothelin antagonists on the hemodynamic response to cyclosporine A. J Am Soc Nephrol 4:1448-1454, 1994
36. BROOKS DP, DEPALMA PD, GELLAI M, NAMBI P, OHLSTEIN EH, ELLIOT JD, GLEASON JG, RUFFOLO RR: Nonpeptide endothelin receptor antagonists. III. Effect of SB 209670 and BQ 123 on acute renal failure in anesthetized dogs. J Pharmacol Exp Ther 271:769-3775, 1994
37. OPGENORTH TJ, WU-WONG JR, SHIOSAKI K: Endothelin-converting enzymes. FASEB J 6:2653-2659, 1992
38. MCMAHON EG, PALOMO MA, MOORE WM, MCDONALD JF, STERN MK: Phosphoramidon blocks the pressor activity of porcine big endothelin-1-(1-39) in vivo and conversion of big endothelin-1-(1-39) to endothelin-1-(1-21) in vitro. Proc Natl Acad Sci USA 88:703-707, 1991
39. HAYNES WG, WEBB DJ: Contribution of endogenous generation of endothelin-1 to basal vascular tone. Lancet 344:852-854, 1994
40. KUKKOLA PJ, SAVAGE P, SAKANE Y, BERRY JC, BILCI NA, GHAI RD, JENG AY: Differential structure-activity relationships of phosphoramidon analogues for inhibition of three metalloproteases: Endothelin-converting enzyme, neutral endopeptidase, and angiotensin-converting enzyme. J Cardiovasc Pharmacol 26:S65-S69, 1995
41. TRAPANI AJ, DE LOMBAERT S, KUZMICH S, JENG AY: Inhibition of big ET-1-induced pressor response by an orally active dual inhibitor of endothelin-converting enzyme and neutral endopeptidase 24.11. J Cardiovasc Pharmacol 26:S69-S71, 1995
42. 22]-big-endothelin-1(19-37): A new potent inhibitor of the endothelin-converting enzyme. J Cardiovasc Pharmacol 25:S72-S74, 1995
43. A selectivity. Potency and solubility modifications. J Med Chem 35:2139-2142, 1992
44. WU-WONG JR, CHIOU WJ, NAUGLES JKE, OPGENORTH TJ: Endothelin receptor antagonists exhibit diminishing potency following incubation with agonist. Life Sci 54:1727-1734, 1994
45. KIM S, MORIMOTO S, KOH E, MIYASHITA Y, OGIHARA T: Comparison of effects of a potassium channel opener BRL34915, a specific potassium ionophore valinomycin and calcium channel blockers on endothelin-induced vascular contraction. Biochem Biophys Res Commun 164:1003-1008, 1989
46. LAWSON K, MARTIN DJ, ZAZZA-SUDRIEZ E, ARMSTRONG JM, HICKS PE: Endothelin-1 attenuates the vasodilator responses to BRL-38227 and Ro 31-6930, but not RP-49356 or nitrendipine, in the spontaneously hypertensive rat. Br J Pharmacol 104:54P, 1991
47. HAYNES WG, WEBB DJ: Selective antagonism of endothelin-1 induced vasoconstriction by the potassium channel opening agent cromakalim. J Hypertens 9:1089-1091, 1991
48. KRAMER HJ, BAECKER A, BOKEMEYER D, MEYER-LEHNERT H: Atrial natriuretic peptide and endothelin: Modulators of renal function. Clin Invest 72:703-705, 1992
49. SAKAMOTO H, SASAKI S, NAKAMURA Y, FUSHIMI K, MARUMO F: Regulation of endothelin-1 production in cultured rat mesangial cells. Kidney Int 41:350-355, 1992
50. MILLER WL, REDFIELD MM, BURNETT JC JR: Integrated cardiac, renal, and endocrine actions of endothelin. J Clin Invest 83:317-320, 1989
51. TOMITA K, UJHE K, NAKANISHI T, TOMITA S, MATSUDA O, ANDO K, SHICHIRI M, HIRATA Y, MARUMO F: Plasma endothelin levels in patients with acute renal failure. N Engl J Med 324:1127, 1989
52. KOYAMA H, NISHZAWA Y, MOKII NH, TABATA T, INOUE T, YAMAJI T: Plasma endothelin levels in patients with uraemia. Lancet i:991-992, 1989
53. STOCKENHUBER F, GOTTSAUNER-WOLF M, MAROSI L, LIEBISCH B, KURZ RW, BLACKE P: Plasma levels of endothelin in chronic failure and after renal transplantation. Clin Sci 82:255-258, 1992
54. PERICO N, RUGGENENTI P, GASPARI F, MOSCONI L, BENIGNI A, AMUCHASTEGUI CS, GASPARINI F, REMUZZI G: Daily renal hyperperfusion induced by cyclosporine in patients with renal transplantation. Transplantation 54:56-60, 1992
55. BENIGNI A, PERICO N, GASPARI F, ZOJA C, BELLIZZI L, GABANELLI M, REMUZZI G: Increased renal endothelin production in rats with reduced renal mass. Am J Physiol 260:F331-F339, 1991
56. BROOKS DP, CONTINO LC, STORER B, OHLSTEIN E: Increased endothelin excretion in rats with renal failure induced by partial nephrectomy. Br J Pharrmacol 104:987-989, 1991
57. ORISIO S, BENIGNI A, BRUZZI I, CORNA D, PERICO N, ZOJA C, BENATTI L, REMUZZI G: Renal endothelin gene expression is increased in remnant kidney and correlates with disease progression. Kidney Int 43:354-358, 1993
58. KING AJ, BRENNER BM, ANDERSON S: Endothelin: A potent renal and systemic vasoconstrictor peptide. Am J Physiol 256:F1051-F1058, 1989
59. KON V, YOSHIOKA T, FOGO A, ICHIKAWA I: Glomerular actions of endothelin in vivo. J Clin Invest 83:1762-1767, 1989
60. EDWARDS RM, TRIZNA W, OHLSTEIN EH: Renal microvascular effects of endothelin. Am J Physiol 259:F217-F221, 1990
61. KATOH T, CHANG H, UCHIDA S, OKUDA T, KUROKAWA K: Direct effects of endothelin in the rat kidney. Am J Physiol 258:F397-F402, 1990
62. SORENSEN SS, MADSEN JK, PEDERSEN EB: Systemic and renal effect of intravenous infusion of endothelin-1 in healthy human volunteers. Am J Physiol 266:F411-F418, 1994
63. OKEN DE: Theoretical analysis of pathogenetic mechanisms in experimental acute renal failure. Kidney Int 24:16-26, 1983
64. SUGIURA M, INAGAMI T, KON V: Endotoxin stimulates endothelin-release in vivo and in vitro as determined by radio-immunoassay. Biochem Biophys Res Commun 16:1220-1227, 1989
65. BUNCHMANN TE, BROOKSHIRE CA: Cyclosporine-induced synthesis of endothelin by cultured human endothelial cells. J Clin Invest 88:310-314, 1991
66. NAKAHAMA H: Stimulatory effect of cyclosporine A on endothelin secretion by a cultured renal epithelial cell line, LLC-PKI cells. Eur J Pharmacol 180:191-192, 1990
67. HEYMAN SN, CLARK BA, KAISER N, SPOKES K, ROSEN S, BREZIS M, EPSTEIN FM: Radiocontrast agents induce endothelin release in vivo and in vitro. J Am Soc Nephrol 3:58-62, 1992
68. MINO N, KOBAYASHI M, NAKAJIMA A, AMANO H, SHIMAMOTO, ISHIKAWA K, WATANABE K, NISHIKIBE M, YANO M, IKEMOTO F: Protective effect of a selective endothelin receptor antagonist, BQ-123, in ischaemic acute renal failure in rats. Eur J Pharmacol 221:77-81, 1992
69. MORISE Z, UEDA M, AIURA K, ENDO M, KITAJIMA M: Pathophysiologic role of endothelin-1 in renal function in rats with endotoxin shock. Surgery 115:199-204, 1994
70. BADR KF: Sepsis-associated renal vasoconstriction: Potential targets for future therapy. Am J Kidney Dis 20:207-213, 1992
71. KIVLIGHN SD, GABEL RA, SIEGL PKS: Effects of BQ-123 on renal function and acute cyclosporine-induced renal function. Kidney Int 45:131-136, 1994
72. FOGO A, HELLINGS S, INAGAMI T, KON V: Endothelin receptor antagonism is protective in in vivo acute cyclosporine toxicity. Kidney Int 42:770-774, 1992
73. A receptor antagonist in the rat. J Clin Invest 93:900-906, 1994
74. PHILLIPS PA, ROLLS KA, BUREEL LM, CASLEY D, ALDRED KL, HARDY KJ: Vascular endothelin responsiveness and receptor characteristics in vitro and effects of endotlielin receptor blockade in vivo in cyclosporin hypertension. Clin Exp Pharmacol Physiol 21:223-226, 1994
75. OHTA K, HIRATA Y, SHICHIRI M, KANNO K, EMORI T, TOMITA K, MARUMO F: Urinary excretion of endothelin-1 in normal subjects and patients with renal disease. Kidney Int 39:307-311, 1991
76. NAKAMURA T, FUKUI M, EBIHARA I, OSADA S, TAKAHASHI T, TOMINO Y, KOIDE H: Effects of a low-protein diet on glomerular endothelin family gene expression in experimental focal glomerular sclerosis. Cli Sci 88:29-37, 1995
77. FUKUI M, NAKAMURA T, EBIHARA I, OSADA S, TOMINO Y, MASAKI T, GOTO K, FURUICHI Y, KOIDE H: Gene expression for endothelins and their receptors in glomeruli of diabetic rats. J Lab Clin Med 122:149-156, 1993
78. FUKUDA K, YANAGIDA T, OKUDA S, TAMAKI K, ANDO T, FUJISHIMA M: Role of endothelin as a mitogen in experimental glomerulonephritis in rats. Kidney Int 49:1320-1329, 1996
79. BATTISTINI B, CHAILLER P, D'ORLEANS-JUSTE P, BRIERE N, SIROIS P: Growth regulatory properties of endothelins. Peptides 14:385-399, 1993
80. RUIZ-ORTEGA M, GOMEZ-GARRE D, ALCAZAR R, PALACIOS I, BUSTOS C, GONZALEZ S, GONZALAR E, EJIDO J: Involvement of angiotensin II and endothelin in matrix protein production and renal sclerosis. J Hypertens 12(Suppl 4):S51-S58, 1994
81. BENIGNI A, ZOJA C, CORNA D, ORISIO S, LONGARETTI L, BERTANI T, REMUZZI G: A specific endothelin subtype A receptor antagonist protects against injury in renal disease progression. Kidney Int 44:440-444, 1993
82. BENIGNI A, ZOJA C, CORNA D, ORISIO S, REMUZZI G: Role of renal endothelin type B receptor in experimental progressive renal disease. (abstract) J Am Soc Nephrol 5:573, 1994
83. B receptor antagonist improves proteinuria and glomerular lesions in a normotensive rat model of immune complex nephritis. (abstract) J Am Soc Nephrol 6:866, 1995
84. WILKINS FC JR, ALBEROLA A, MIZELLE HL, OPGENORTH TJ, GRANGER JP: Chronic pathophysiological circulating endothelin levels produce hypertension in conscious dogs. J Cardiovasc Pharmacol 22:S325-S327, 1993
85. YOKOKAWA K, TAHARA H, KOHNO M, MURAKAWA K, YASUNARI K, NAKAGAWA K, HAMADA T, OTANI S, YANAGISAWA M, TAKEDA T: Hypertension associated with endothelin-secreting malignant hemangioendothelioma. Ann Intern Med 114:213-215, 1991
86. HAYNES WG, FERRO CJ, O'KANE PJK, SOMERVILLE D, LOMAX CC, WEBB DJ: Systemic endothelin receptor blockade decreases peripheral vascular resistance and blood pressure in man. Circulation (in press)
87. CLOZEL M, BREU V, BURRI K, CASSAL JM, FISCHLI W, GRAY GA, HIRTH G, LOEFFLER BM, MUFLLER M, NEIDHART W, RAMUZ H: Pathophysiological role of endothelin revealed by the first orally active endothelin receptor antagonist. Nature 365:259-261, 1993
88. SCHIFFRIN EL, LARIVIERE R, LI JS, SVENTEK P, TOUYZ RM: Deoxycorticosterone acetate plus salt induces overexpression of vascular endothelin-1 and severe vascular hypertrophy in spontaneously hypertensive rats. Hypertension 25:769-773, 1995
89. SCHIFFRIN EL: Endothelin: Potential role in hypertension and vascular hypertrophy. Hypertension 25:1135-1143, 1995
90. ONG, ACM, JOWETT TP, FIRTH JD, BURTON S, KARET FE, FINE LG: An endotlielin-1 mediated autocrine growth loop involved in human renal tubular regeneration. Kidney Int 48:390-401, 1995
91. NIR A, CLAVELL AL, HEUBLEIN D, AARHUS LL, BURNETT JC JR: Acute hypoxia and endogenous renal endothelin. J Am Soc Nephrol 4:1920-1924, 1994
92. CLAVELL AL, STINGO AJ, MARGULIES KB, BRANDT RR, BURNETT JC JR: Role of endothelin receptor subtypes in the in vivo regulation of renal function. Am J Physiol 268:F455-F460, 1995
93. YOSHIMURA A, IWASAKI S, INUI K, IDEURA T, KOSHIKAWA S, YANAGISAWA M, MASAKI T: Endothelin-1 and endothelin B type receptor are induced in mesangial proliferative nephritis in the rat. Kidney Int 48:1290-1297, 1995
94. GELLAI M, DEWOLF R, PULLEN M, NAMBI P: Distribution and functional role of renal ET receptor subtypes in normotensive and hypertensive rats. Kidney Int 46: 1287-1294, 1994
95. NAMBI P, PULLEN M, CONTINO LC, BROOKS DP: Upregulation of renal endothelin receptors in rats with cyclosporine A-induced nephrotoxicity. Eur J Pharmacol 187:113-116, 1990
96. HOCHER B, ZART R, DIEKMANN F, GROSS P, DISTLER A, BAUER C: Renal endothelin system in rats with liver cirrhosis. Br J Pharmacol 118:220-227, 1996
97. B-receptor-mediated effects of endothelin-1 by BQ-123 in the anaesthetized rat. Br J Pharmacol 107:912-918, 1992
98. WELLINGS RP, CORDER R, WARNER TD, CRISTOL JP, THIEMERMANN C, VANE JR: Evidence from receptor antagonists of an important role for ETB-receptor-mediated vasoconstrictor effects of endothelin-1 in the rat kidney. Br J Pharmacol 111:515-520, 1994
99. CRISTOL JP, WARNER TD, THIEMERMANN C, VANE JR: Mediation via different receptors of the vasoconstrictor effects of endothelins and sarafotoxins in the systemic circulation and renal vasculature of the anestetized rat. Br J Pharmacol 108:776-779, 1993
100. B, receptors mediate contraction to endothelin-1 in human blood vessels. Circulation 89:1203-1208, 1994
101. B receptors cause vasoconstriction of human resistance and capacitance vessels in vivo. Circulation 92:357-363, 1995
102. KAASJAGER KAH, SHAW S, KOOMANS HA, RABELINK TJ: Systemic and renal effects of endothelin-1 and endothelin-3 in humans. (abstract) J Am Soc Nephrol 1997 (in press)
103. KIOWSKI W, SÜTSCH G, HUNZIKER P, MÜLLER P, KIM J, OECHSLIN E, SCMITT R, JONES R, BERTEL G: Evidence for endothelin-1-mediated vasoconstriction in severe chronic heart failure. Lancet 346:732-736, 1995
104. EPSTEIN M: Calcium antagonists and the kidney. J Cardiovasc Pharmacol 24(Suppl A):S18-S24, 1994
105. BRADY HR, SINGER GG: Acute renal failure. Lancet 346:1533-1540, 1995
106. KAASJAGER KAH, KOOMANS HA, RABELINK TJ: Interactions of nifedipine with the renovascular effects of endothelin in humans. J Pharmacol Exp Ther 275:306-311, 1995
107. KAASJAGER KAH, KOOMANS HA, RABELINK TJ: Effectiveness of enalapril versus nifedipine to antagonize blood pressure and renal response to endothelin in humans. Hypertension 25:620-625, 1995
108. BURKE TJ, ARNOLD PE, GORDON JA, BULGER RE, DOBYAN DC, SCHRIER RW: Protective effect of intrarenal calcium membrane blockers before or after renal ischemia. J Clin Invest 74:1830-1841, 1984
109. JAFFER FE, KNAUSS TC, POPTIC E, ABBOUD HE: Endothelin stimulates PDGF secretion in cultured human mesangial cells. Kidney Int 38:1193-1198, 1990
110. KOHNO M, HORIO T, YOKOKAWA K, YASUNARI K, KURIHARA N, TAKEDA T: Endothelin modulates the mitogenic effect of PDGF on glomerular mesangial cells. Am J Physiol (in press)
111. KURIHARA H, YOSHIZUMI M, SUGIYAMA T, TAKAKU F, YANAGISAWA M, MASAKI T, HAMAOKI M, KATO H, YAZAKI Y: Transforming growth factor-β stimulates the expression of endothelin mRNA by vascular endothelial cells. Biochem Biophys Res Commun 159:1435-1440, 1989
112. BAKRIS GL, FAIRBANKS R, TRAISH A: Arginine Vasopressin stimulates human mesangial cell production of endothelin. J Clin Invest 87:1158-1164, 1991
113. ITO H, HIRATA Y, ADACHI S: Endothelin-1 is an autocrine/paracrine factor in the mechanism of angiotensin-induced hypertrophy in cultured rat cardiomyocytes. J Clin Invest 92:398-403, 1993
114. HUNLEY TE, FOGO A, IWASAKI S, KON V: Endothelin A receptor mediates functional but not structural damage in chronic cyclosporin nephrotoxicity. J Am Soc Nephrol 5:1718-1723, 1995
115. KON V, HUNLEY TE, FOGO A: Combined antagonism of endothelin a/b receptors links endothelin to vasoconstriction whereas angiotensin II effects fibrosis. Transplantation 60:89-95, 1995